Business
Johnson & Johnson single-dose vaccine shown to be effective against COVID-19 – ABC News
The single-shot option is not as strong as some of its two-shot rivals, however it could be potentially helpful for a world in dire need of more doses.
Johnson & Johnson’s (J&J) vaccine candidate appears to protect against COVID-19 with just one shot of the dose.
Key points:
- Johnson & Johnson says trial results show its one-shot vaccine is 66 per cent effective against COVID-19
- While promising, it is still behind many rivals who are using a two-shot vaccine
- The company says trying to create a vaccine which requires one shot is worthwhile as the virus continues to spread
The single-shot option is not as strong as some of its two-shot rivals, however…
Continue Reading
-
Noosa News19 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business20 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Noosa News16 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Business18 hours agoEverything you need to know about the Coles dividend